A prospective trial evaluating the ability of preoperative CT scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, Fallopian tube, and peritoneal cancer

Suidan, Rudy

59 - Scientific Plenary
A prospective trial evaluating the ability of preoperative CT scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, Fallopian tube, and peritoneal cancer

Sunday, March 23, 2014: 11:20 AM

Ballroom B/C (Tampa Convention Center)

R. S. Suidan¹, P. T. Ramirez², D. Sarasohn¹, J. Teitcher¹, S. Mironov¹, R. Iyer², Q. Zhou¹, H. Paul³, M. Osaka² and D. S. Chi³
¹Memorial Sloan Kettering Cancer Center, New York, NY, ²The University of Texas MD Anderson Cancer Center, Houston, TX, ³Memorial Sloan-Kettering Cancer Center, New York, NY

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

59 - Scientific Plenary
A prospective trial evaluating the ability of preoperative CT scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, Fallopian tube, and peritoneal cancer

59 - Scientific Plenary A prospective trial evaluating the ability of preoperative CT scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, Fallopian tube, and peritoneal cancer

59 - Scientific Plenary
A prospective trial evaluating the ability of preoperative CT scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, Fallopian tube, and peritoneal cancer